Transactions

Below are transactions completed by BroadOak bankers at previous firms.


Year

 

Transaction

 

07/2006
Sale of In Vitro Technologies, Inc to Celsis International Plc.
03/2006
Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory.
12/2005
Acquisition of Control Delivery Systems.
10/2005
Sale of NovaScreen Biosciences to Caliper Life Sciences.
10/2005
Merger with xtrana.
07/2004
Sale of high content screening instrumentation company to BD Biosciences.
07/2001
Sale of Sybron Biochemical Division to Novozymes.
05/2001
Sale of publicly traded medical device company to Gyrus Group.
02/2001
Sale of Munich based medical device company to ResMed.
11/2000
Implementation of Shareholders Rights Plan.
08/2000
Acquisition of publicly traded drug discovery tools company LJL BioSystems.
Go back